Reuters logo
BRIEF-Genfit cash and cash equivalents at March 31 rises to 137.0 million euros
April 24, 2017 / 6:54 AM / in 8 months

BRIEF-Genfit cash and cash equivalents at March 31 rises to 137.0 million euros

April 24 (Reuters) - Genfit SA:

* Q1 revenue 26,000 euros ($28,176.20) versus 88,000 euros year ago

* Cash and cash equivalents at March 31 137.0 million euros versus 102.8 million euros year ago

* Phase 2A clinical trial of Elafibranor is entering its active enrollment phase Source text for Eikon: Further company coverage: ($1 = 0.9228 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below